USPTO serial 79144043
QUANTINOVA
Reviewed by CopyMark Law Group
Reg. 4603851Status 706Registered
- Filing date
- Status date
- Registration date
- Sep 16, 2014
- Examiner
- ELTON, DAVID JONATHAN
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with QUANTINOVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Victoria Friedman
VICTORIA FRIEDMAN Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, reagents and solvents for scientific and research use in the nature of sample preparation and for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids and enzymes; polymerase chain reaction (PCR) reagents for industrial and scientific purposes; chemical reagents for amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for real-time and quantitative amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; chemical reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; chemical reagents for conversion of RNA into cDNA for scientific research purposes; test kits comprising chemical preparations for industrial and scientific purposes, kits comprising reagents and solvents for scientific research use for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids, namely, kits comprising polymerase chain reaction (PCR) reagents for industrial and scientific research purposes; chemical reagents for amplification and detection of nucleic acids for industrial and scientific purposes; kits comprising chemical reagents for real-time and quantitative amplification and detection of nucleic acids for industrial and scientific purposes; kits comprising chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; kits comprising chemical reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; kits comprising chemical reagents for conversion of RNA into cDNA for scientific research purposes | ACTIVE | — |
| 005 | [Diagnostic reagents for medical and veterinary medical purposes, medical diagnostic reagents for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids and enzymes; polymerase chain reaction (PCR) reagents for medical and veterinary medical purposes; reagents for amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for real-time and quantitative amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for complementary DNA (cDNA) synthesis for medical and veterinary medical purposes; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes, kits comprising medical diagnostic reagents for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids; kits comprising polymerase chain reaction (PCR) reagents for medical and veterinary medical purposes; kits comprising reagents for amplification and detection of nucleic acids for medical and veterinary medical purposes; kits comprising reagents for real-time and quantitative amplification and detection of nucleic acids for medical and veterinary medical purposes; kits comprising reagents for complementary DNA (cDNA) synthesis for medical and veterinary medical purposes] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 14, 2026 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Oct 19, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 19, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 19, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 18, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 30, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Sep 16, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Aug 31, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Nov 3, 2021 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 20, 2021 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 20, 2021 | INPC | INVALIDATION PROCESSED | — |
| Sep 5, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 5, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jan 5, 2021 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Dec 7, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 21, 2020 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Oct 18, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 13, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 24, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 24, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 16, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 16, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 22, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 1, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 11, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| May 27, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 15, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 15, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2014 | ALIE | ASSIGNED TO LIE | — |
| May 1, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 31, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 31, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 30, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 29, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 21, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 20, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |